Home » Newsletters » BioWorld Asia

BioWorld Asia

April 26, 2000

View Archived Issues

CeNeS, Bioglan Expand Alliance On Pain Control, Drug Delivery

Stimulating Environment Delays Onset Of Huntington's In Mice

Artemis Launching International Project On Screening Zebrafish

Devgen Getting $15M Through Expansion Of Deal With FMC

Astex Formed To Improve Upon Speed Of X-Ray Crystallography

Biovector Moves Lipomel Into Phase II Studies For Cancers

Prana Using IPO Proceeds To Further Develop CNS Therapies

Girindus Plans To Go Public On German Market Next Month

GeneFocus, Collaborators Plan New Biochip Facility In Ottawa

Flamel Validates Medusa System In Study Involving Insulin Delivery

French Officials Release Details Of GM Oil Seed Rape Trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...